参考文献/References:
[1] 王伟,曹庆华,孙光玲,等.脑白质病变与帕金森病患者运动症状及非运动症状的相关性分析[J].中华全科医学,2022,20(2):237-239.
[2] Oltra J,Campabadal A,Segura B,et al.Disrupted functional connectivity in PD with probable RBD and its cognitive correlates[J].Sci Rep,2021,11(1):24351.
[3] Kormas C,Zalonis I,Evdokimidis I,et al.The severity of executive dysfunction among different PD-MCI subtypes[J].Appl Neuropsychol Adult,2022,29(4):546-550.
[4] Devignes Q,Daoudi S,Viard R,et al.Heterogeneity of PD-MCI in candidates to subthalamic deep brain stimulation: associated cortical and subcortical modifications[J].J Parkinsons Dis,2022,12(5):1507-1526.
[5] Goldman JG,Holden S,Ouyang BC,et al.Diagnosing PD-MCI by MDS task force criteria: how many and which neuropsychological tests?[J].Mov Disord,2015,30(3):402-406.
[6] Postuma RB,Berg D,Stern M,et al.MDS clinical diagnostic criteria for Parkinson's disease[J].Mov Disord,2015,30(12):1591-1601.
[7] 扎圣宇,马建芳,陈生弟.快动眼睡眠行为障碍筛查量表的应用评价[J].诊断学理论与实践,2016,15(3):258-262.
[8] Kataoka H,Sugie K.Association between fatigue and Hoehn-Yahr staging in Parkinson's disease:eight-year follow-up study[J].Neurol Int,2021,13(2):224-231.
[9] Torres-Yaghi Y,Hattori N,Rascol O,et al.Istradefylline effects on tremor dominance(TD)and postural instability and gait difficulty(PIGD)[J].Clin Park Relat Disord,2023,9:100224.
[10] Zitser J,Allen IE,Falgàs N,et al.Pittsburgh sleep quality index(PSQI)responses are modulated by total sleep time and wake after sleep onset in healthy older adults[J].PLoS One,2022,17(6):e0270095.
[11] Nikolova VL,Cleare AJ,Young AH,et al.Acceptability, tolerability, and estimates of putative treatment effects of probiotics as adjunctive treatment in patients with depression:a randomized clinical trial[J].JAMA Psychiatry,2023,80(8):842-847.
[12] Chen X,Zhang TT,Shan XY,et al.High-frequency repetitive transcranial magnetic stimulation alleviates the cognitive side effects of electroconvulsive therapy in major depression[J].Front Psychiatry,2022,13:1002809.
[13] Neff C,Wang MC,Martel H.Using the PDQ-39 in routine care for Parkinson's disease[J].Parkinsonism Relat Disord,2018,53:105-107.
[14] Jia XF,Wang ZH,Huang FF,et al.A comparison of the mini-mental state examination(MMSE)with the montreal cognitive assessment(MoCA)for mild cognitive impairment screening in Chinese middle-aged and older population:a cross-sectional study[J].BMC Psychiatry,2021,21(1):485.
[15] 张欣,王红,张李娜,等.伴或不伴快动眼睡眠行为障碍的帕金森病临床特点比较[J].脑与神经疾病杂志,2023,31(2):71-74.
[16] Leng B,Sun HR,Li MF,et al.Blood neuroexosomal excitatory amino acid transporter-2 is associated with cognitive decline in Parkinson's disease with RBD[J].Front Aging Neurosci,2022,14:952368.
[17] Baig F,Kelly MJ,Lawton MA,et al.Impulse control disorders in Parkinson disease and RBD:a longitudinal study of severity[J].Neurology,2019,93(7):e675-e687.
[18] Marques A,Pereira B,Figorilli M,et al.Decision making under uncertainty in Parkinson's disease with Rem sleep behavior disorder[J].Sleep Med,2022,90:214-221.
[19] 万志荣,赵静,解金金,等.女性帕金森病患者剂末现象的临床特征和危险因素分析[J].神经损伤与功能重建,2023,18(8):461-464, 473.
[20] Chong-Wen W,Sha-Sha L,Xu E.Predictors of rapid eye movement sleep behavior disorder in patients with Parkinson's disease based on random forest and decision tree[J].PLoS One,2022,17(6):e0269392.
[21] 杨利,王敏,任庆惠,等.严重嗅觉减退的帕金森病患者内在大脑活动指标的空间和时间一致性改变[J].磁共振成像,2023,14(10):12-19.
[22] 焦方阳,陶俊,孙金菊,等.帕金森病脑多巴胺转运体分布、葡萄糖代谢及临床症状评分的相关性[J].中华核医学与分子影像杂志,2019,38(6):349-355.